380 results on '"Alharethi R"'
Search Results
2. Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve Post-LVAD Reverse Cardiac Remodeling
Catalog
Books, media, physical & digital resources
3. (488) Impaired Liver Function is Associated with Hypotension and Elevated Right Atrial Pressure but Not Depressed Cardiac Index in Chronic Heart Failure
4. Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database
5. Large Variation in Heart Transplant Selection Practices During the COVID-19 Pandemic
6. Multicenter-Derived Clinical Score Predicts Structural and Functional Cardiac Improvement in Chronic Heart Failure Patients Undergoing Mechanical Circulatory Support
7. Left Ventricular Assist Device-Mediated Cardiac Recovery: Impact of Diabetes Mellitus and Glycemic Control
8. Single-Center Analysis of Patients with HeartMate 3 LVAD External Outflow Graft Obstruction
9. (154) - Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve Post-LVAD Reverse Cardiac Remodeling
10. (156) - Myocardial Functional Improvement is Associated with Improved HF-Related Outcomes in Patients While on Durable LVAD: An STS INTERMACS Analysis
11. Effect of Blood Product Transfusion–Induced Tolerance on Incidence of Cardiac Allograft Rejection
12. Predicting Right Ventricular Failure Following Left Ventricular Assist Device Support: A Derivation-Validation Multicenter Risk Score
13. Comparison of Cardiac Reverse Remodeling between Older and Newer Generation Continuous-Flow LVAD
14. The Impact of Diabetes Mellitus and Glycemia on Myocardial Recovery
15. Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy. A Metanalysis of Prospective Studies.: Abstract# 1199 Poster Board #-Session: P66-III
16. Elevated Resting Heart Rate in Heart Transplant Recipients: Innocent Bystander or Adverse Prognostic Indicator?: Abstract# 316
17. (332) Left Ventricular Functional Improvement is Associated with Lower Rates of Device Thrombosis in Patients on Durable Mechanical Circulatory Support
18. (215) Multicenter Development and Validation of a Machine Learning Model to Predict Myocardial Recovery During LVAD Support: The UCAR Score
19. (772) Fully Magnetically Levitated Continuous Flow Left Ventricular Assist Device: Are We There Yet?
20. Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant
21. The Role of Non-Glycolytic Glucose Metabolism in Myocardial Recovery Following Mechanical Unloading and Circulatory Support in Chronic Heart Failure
22. Predicting Cardiac Structural and Functional Improvement Induced by Mechanical Unloading in Chronic Heart Failure: A Derivation-Validation Multicenter Study
23. Magnitude and Time Course of Left Atrial Remodeling Changes in Patients Undergoing Chronic Left Ventricular Assist Device Support
24. Clinical Framework for the Staging of Reverse Cardiac Remodeling with Mechanical Unloading and Circulatory Support
25. Global Coronary Artery Flow Reserve after Heart Transplantation: Recipient or Donor Age-Driven?
26. Predicting Right Ventricular Failure in Chronic Heart Failure Patients Receiving Left Ventricular Assist Device
27. Reverse Myocardial Remodeling with Centrifugal versus Axial-Flow Left Ventricular Assist Device in Chronic Heart Failure Patients
28. P5419Cardiac reverse remodeling and recovery in dilated cardiomyopathy medication-naive patients requiring durable left ventricular assist device support
29. P2628Predicting cardiac recovery before durable left ventricular assist device implantation in advanced heart failure patients
30. Does Transport Time or Distance from Hospital Affect Survival in Extracorporeal Membrane Oxygenation (ECMO) Patients?
31. Predicting Cardiac Recovery before Durable Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients
32. Accelerated Cardiac Allograft Vasculopathy: A Clinical and Pathologic Correlation Study
33. Cardiac Reverse Remodeling and Recovery in Dilated Cardiomyopathy Medication-Naive Patients Requiring Durable Left Ventricular Assist Device Support
34. Are Gene Expression Profile Testing Scores Associated with New Onset Cardiac Allograft Vasculopathy?
35. Glycosylated Hemoglobin (HbA1c) as a Predictor of Adverse Outcomes in Left Ventricular Assist Device (LVAD) Patients
36. 4992Cardiac rotational mechanics in advanced heart failure patients undergoing cardiac assist device implantation predict favorable myocardial functional response
37. Ultrastructural Alterations in Explanted Failed Cardiac Allografts: Insights into "Chronic Rejection"
38. Excellent Outcomes After Heart Transplantation in Stable, Highly-Sensitized Heart Transplant Recipients Using a Wait and Match Strategy
39. Unique Characteristics of Allograft Microvasculature in Patients with Severe Symptomatic Cardiac Allograft Vasculopathy
40. Cardiac Rotational Mechanics as a Predictor of Favorable Functional Response Induced by Cardiac Assist Devices in Advanced Heart Failure
41. Shared genetic etiology of peripartum and dilated cardiomyopathies
42. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
43. Myocardial and End-Organ Response after Long-Term Mechanical Unloading with Continuous-Flow Left Ventricular Assist Device: Axial- Versus Centrifugal-Flow
44. Comparing Changes in Aortic and Mitral Valve Function with Axial (AX) Versus Centrifugal (CR) Left Ventricular Assist Devices
45. A Mock Circulatory System to Research the HeartWare Pump Flow Waveform
46. Characteristics and Co-Morbidities in Heart Transplant Recipients Who Survive into Their Eighties
47. Relationship of Myocardial Fibrosis with the Potential of Mechanical Unloading to Induce Favorable Cardiac Structural and Functional Response
48. Capillary Damage and Fibrin in Heart Transplantation: Significant Impact on Survival with or without Rejection
49. Impact of Venous-Arterial Extracorporeal Membrane Oxygenation Standardized Guidelines: Worth the Effort?
50. Clearance of C3d Immunostaining Occurs More Often and Earlier Than Clearance of C4d after Antibody Mediated Rejection: An Earlier Marker for Resolving Rejection?
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.